Business · 25/07/2014
FDA Classifies Implantable Transprostatic Tissue Retractor System as Class II Device with Special Controls
The FDA has classified the implantable transprostatic tissue retractor system as a Class II device with special controls, aiming to ensure the device's safety and effectiveness.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →